Follow this preprint
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk
View ORCID ProfileDaniel R. Barnes, View ORCID ProfileJonathan P. Tyrer, View ORCID ProfileJoe Dennis, Goska Leslie, Manjeet K. Bolla, Michael Lush, Amber M. Aeilts, Kristiina Aittomäki, Nadine Andrieu, Irene L. Andrulis, Hoda Anton-Culver, Adalgeir Arason, Banu K. Arun, Judith Balmaña, Elisa V. Bandera, Rosa B. Barkardottir, Lieke P.V. Berger, Amy Berrington de Gonzalez, Pascaline Berthet, Katarzyna Białkowska, Line Bjørge, Amie M. Blanco, Marinus J. Blok, Kristie A. Bobolis, Natalia V. Bogdanova, View ORCID ProfileJames D. Brenton, Henriett Butz, Saundra S. Buys, Maria A. Caligo, Ian Campbell, Carmen Castillo, Kathleen B.M. Claes, GEMO Study Collaborators, EMBRACE Collaborators, Sarah V. Colonna, Linda S. Cook, Mary B. Daly, Agnieszka Dansonka-Mieszkowska, Miguel de la Hoya, Anna deFazio, Allison DePersia, Yuan Chun Ding, Susan M. Domchek, Thilo Dörk, Zakaria Einbeigi, Christoph Engel, D. Gareth Evans, Lenka Foretova, Renée T. Fortner, Florentia Fostira, Maria Cristina Foti, Eitan Friedman, Megan N. Frone, Patricia A. Ganz, Aleksandra Gentry-Maharaj, Gord Glendon, Andrew K. Godwin, Anna González-Neira, Mark H. Greene, Jacek Gronwald, Aliana Guerrieri-Gonzaga, Ute Hamann, Thomas v.O. Hansen, Holly R. Harris, Jan Hauke, Florian Heitz, Frans B.L. Hogervorst, Maartje J. Hooning, John L. Hopper, Chad D Huff, David G. Huntsman, Evgeny N. Imyanitov, kConFab Investigators, Louise Izatt, Anna Jakubowska, Paul A. James, Ramunas Janavicius, Esther M. John, View ORCID ProfileSiddhartha Kar, Beth Y. Karlan, Catherine J. Kennedy, Lambertus A.L.M. Kiemeney, Irene Konstantopoulou, Jolanta Kupryjanczyk, Yael Laitman, Ofer Lavie, Kate Lawrenson, Jenny Lester, Fabienne Lesueur, Carlos Lopez-Pleguezuelos, Phuong L. Mai, Siranoush Manoukian, Taymaa May, View ORCID ProfileIain A. McNeish, Usha Menon, Roger L. Milne, Francesmary Modugno, Jennifer M. Mongiovi, Marco Montagna, Kirsten B. Moysich, Susan L. Neuhausen, Finn C. Nielsen, Catherine Noguès, Edit Oláh, Olufunmilayo I. Olopade, Ana Osorio, Laura Papi, Harsh Pathak, Celeste L. Pearce, Inge S. Pedersen, Ana Peixoto, Tanja Pejovic, View ORCID ProfilePei-Chen Peng, Beth N. Peshkin, Paolo Peterlongo, C. Bethan Powell, Darya Prokofyeva, Miquel Angel Pujana, Paolo Radice, Muhammad U. Rashid, Gad Rennert, George Richenberg, Dale P. Sandler, Naoko Sasamoto, Veronica W. Setiawan, Priyanka Sharma, Weiva Sieh, Christian F. Singer, Katie Snape, Anna P. Sokolenko, Penny Soucy, Melissa C. Southey, Dominique Stoppa-Lyonnet, Rebecca Sutphen, Christian Sutter, Manuel R. Teixeira, Kathryn L. Terry, Liv Cecilie V. Thomsen, Marc Tischkowitz, Amanda E. Toland, Toon Van Gorp, Ana Vega, Digna R. Velez Edwards, Penelope M. Webb, Jeffrey N. Weitzel, Nicolas Wentzensen, Alice S. Whittemore, Stacey J. Winham, Anna H. Wu, Siddhartha Yadav, Yao Yu, Argyrios Ziogas, Andrew Berchuck, Fergus J. Couch, Ellen L. Goode, Marc T. Goodman, Alvaro N. Monteiro, Kenneth Offit, Susan J. Ramus, Harvey A. Risch, Joellen M. Schildkraut, Mads Thomassen, Jacques Simard, Douglas F. Easton, Michelle R. Jones, Georgia Chenevix-Trench, Simon A. Gayther, Antonis C. Antoniou, Paul D.P. Pharoah the Ovarian Cancer Association Consortium and the Consortium of Investigators of Modifiers of BRCA1 and BRCA2
doi: https://doi.org/10.1101/2024.02.29.24303243
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Daniel R. Barnes
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Jonathan P. Tyrer
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Joe Dennis
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Goska Leslie
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Manjeet K. Bolla
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Michael Lush
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Amber M. Aeilts
2Department of Internal Medicine, Division of Human Genetics, The Ohio State University, Columbus, OH, USA
Kristiina Aittomäki
3Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland
Nadine Andrieu
4Inserm U900, Paris, France
5Institut Curie, Paris, France
6Mines ParisTech, Fontainebleau, France
7PSL Research University, Paris, France
Irene L. Andrulis
8Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada
9Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Canada
Hoda Anton-Culver
10Department of Epidemiology, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, CA, USA
Adalgeir Arason
11Department of Pathology, Landspitali - the National University Hospital of Iceland, Reykjavik, Iceland
12BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland
Banu K. Arun
13Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Judith Balmaña
14Hereditary Cancer Genetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
15Department of Medical Oncology, University Hospital of Vall d’Hebron, Barcelona, Spain
Elisa V. Bandera
16Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA
Rosa B. Barkardottir
11Department of Pathology, Landspitali - the National University Hospital of Iceland, Reykjavik, Iceland
12BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland
Lieke P.V. Berger
17University Medical Center Groningen, Department of Genetics, University of Groningen, Groningen, The Netherlands
Amy Berrington de Gonzalez
18Clinical Cancer Epidemiology, Institute of Cancer Research, London, UK
Pascaline Berthet
19Département de Biopathologie, Centre François Baclesse, Caen, France
Katarzyna Białkowska
20Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland
Line Bjørge
21Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway
22Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway
Amie M. Blanco
23Cancer Genetics and Prevention Program, University of California San Francisco, San Francisco, CA, USA
Marinus J. Blok
24Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands
Kristie A. Bobolis
25City of Hope Clinical Cancer Genetics Community Research Network, Duarte, CA, USA
Natalia V. Bogdanova
26Department of Radiation Oncology, Hannover Medical School, Hannover, Germany
27Gynaecology Research Unit, Hannover Medical School, Hannover, Germany
28N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus
James D. Brenton
29Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK
Henriett Butz
30Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary
31National Tumour Biology Laboratory, National Institute of Oncology, Budapest, Hungary
32Department of Oncology Biobank, National Institute of Oncology, Budapest, Hungary
Saundra S. Buys
33Department of Medicine, Huntsman Cancer Institute, University of Utah Health, Salt Lake City, UT, USA
Maria A. Caligo
34SOD Genetica Molecolare, University Hospital, Pisa, Italy
Ian Campbell
35Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Carmen Castillo
36Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, Barcelona, Spain
Kathleen B.M. Claes
37Centre for Medical Genetics, Ghent University, Gent, Belgium
38Department of Biomolecular Medicine, University of Ghent, Ghent, Belgium
39Cancer Research Institute Ghent, Ghent, Belgium
4Inserm U900, Paris, France
5Institut Curie, Paris, France
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Sarah V. Colonna
40Department of Internal Medicine, Huntsman Cancer Institute, University of Utah Health, Salt Lake City, UT, USA
Linda S. Cook
41Department of Epidemiology, Colorado School of Public Health, University of Colorado, Aurora, CO, USA
Mary B. Daly
42Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA
Agnieszka Dansonka-Mieszkowska
43Department of Pathology and Laboratory Medicine, Institute of Oncology and Maria Sklodowska-Curie Cancer Center, Warsaw, Poland
Miguel de la Hoya
44Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain
Anna deFazio
45Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia
46Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia
47Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
48The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia
Allison DePersia
49Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL, USA
50The University of Chicago Pritzker School of Medicine, Chicago, IL, USA
Yuan Chun Ding
51Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA
Susan M. Domchek
52Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
Thilo Dörk
27Gynaecology Research Unit, Hannover Medical School, Hannover, Germany
Zakaria Einbeigi
53Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Christoph Engel
54Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany
D. Gareth Evans
55Genomic Medicine, Division of Evolution and Genomic Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester Universities Foundation Trust, St. Mary’s Hospital, Manchester, UK
56Genomic Medicine, North West Genomics hub, Manchester Academic Health Science Centre, Manchester Universities Foundation Trust, St. Mary’s Hospital, Manchester, UK
Lenka Foretova
57Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic
Renée T. Fortner
58Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
59Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway
Florentia Fostira
60Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research ‘Demokritos’, Athens, Greece
Maria Cristina Foti
61Veneto Institute of Oncology IOV-IRCSS, Italy
Eitan Friedman
62Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel
63The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Ramat Gan, Israel
64Assuta Medical Center, Tel-Aviv, Israel
Megan N. Frone
65National Cancer Institute, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, Bethesda, MD, USA
Patricia A. Ganz
66Schools of Medicine and Public Health, Division of Cancer Prevention & Control Research, Jonsson Comprehensive Cancer Centre, UCLA, Los Angeles, CA, USA
Aleksandra Gentry-Maharaj
67MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London, UK
Gord Glendon
9Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Canada
Andrew K. Godwin
68Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA
Anna González-Neira
69Human Genotyping Unit-CeGen, Spanish National Cancer Research Centre, Madrid, Spain
70Spanish Network on Rare Diseases, Madrid, Spain
Mark H. Greene
65National Cancer Institute, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, Bethesda, MD, USA
Jacek Gronwald
20Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland
Aliana Guerrieri-Gonzaga
71Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy
Ute Hamann
72Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany
Thomas v.O. Hansen
73Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
74Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Holly R. Harris
75Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA
76Department of Epidemiology, University of Washington, Seattle, WA, USA
Jan Hauke
77Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
78Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
Florian Heitz
79Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany
Frans B.L. Hogervorst
80Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands
Maartje J. Hooning
81Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
John L. Hopper
82Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia
Chad D Huff
83Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
David G. Huntsman
84British Columbia’s Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, BC, Canada
85Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
86Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada
87Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, BC, Canada
Evgeny N. Imyanitov
88Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, St. Petersburg, Russia
89Peter MacCallum Cancer Center, Melbourne, Victoria, Australia
90Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia
Louise Izatt
91Clinical Genetics, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
Anna Jakubowska
20Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland
92Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland
Paul A. James
90Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia
93Parkville Familial Cancer Centre, Peter MacCallum Cancer Center and the Royal Melbourne Hospital, Melbourne, Victoria, Australia
Ramunas Janavicius
94State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania
95Hematology, Oncology and Transfusion Medicine Center, Oncogenetics Unit, Vilnius University Hospital Santaros Clinics, Vilnius, Lithuania
96Department of Human and Medical Genetics, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
Esther M. John
97Department of Epidemiology & Population Sciences, Stanford University School of Medicine, Stanford University, Stanford, CA, USA
98Department of Medicine (Oncology), Stanford University School of Medicine, Stanford University, Stanford, CA, USA
99Stanford Cancer Institute, Stanford University School of Medicine, Stanford University, Stanford, CA, USA
Siddhartha Kar
100Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK
Beth Y. Karlan
101David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, USA
102Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Catherine J. Kennedy
45Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia
46Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia
47Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
Lambertus A.L.M. Kiemeney
103Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands
Irene Konstantopoulou
60Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research ‘Demokritos’, Athens, Greece
Jolanta Kupryjanczyk
43Department of Pathology and Laboratory Medicine, Institute of Oncology and Maria Sklodowska-Curie Cancer Center, Warsaw, Poland
Yael Laitman
63The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Ramat Gan, Israel
Ofer Lavie
104Technion-Israel Institute of Technology, Haifa, Israel
105Carmel Medical Center, Haifa, Israel
Kate Lawrenson
106Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Women’s Cancer Program at the Samuel Oschin Cancer Institute Cedars-Sinai Medical Center, Los Angeles, CA, USA
Jenny Lester
101David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, USA
102Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Fabienne Lesueur
4Inserm U900, Paris, France
5Institut Curie, Paris, France
6Mines ParisTech, Fontainebleau, France
7PSL Research University, Paris, France
Carlos Lopez-Pleguezuelos
107Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain
108Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain
109Escola de Doutoramento Internacional, Universidade de Santiago, Santiago de Compostela, Spain
Phuong L. Mai
110Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Siranoush Manoukian
111Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
Taymaa May
112Princess Margaret Cancer Center, Toronto, Canada
Iain A. McNeish
113Division of Cancer and Ovarian Cancer Action Research Centre, Department Surgery & Cancer, Imperial College London, London, UK
114Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
Usha Menon
67MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London, UK
Roger L. Milne
82Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia
115Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia
116Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia
Francesmary Modugno
117Womens Cancer Research Center, Magee-Womens Research Institute and Hillman Cancer Center, Pittsburgh, PA, USA
118Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Jennifer M. Mongiovi
119Department of Obstetrics and Gynecology, Brigham and Women’s Hospital, Boston, MA, USA
120Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
Marco Montagna
121Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy
Kirsten B. Moysich
122Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
Susan L. Neuhausen
51Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA
Finn C. Nielsen
123Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
Catherine Noguès
124Département d’Anticipation et de Suivi des Cancers, Oncogénétique Clinique, Institut Paoli-Calmettes, Marseille, France
125Aix Marseille Université, INSERM, IRD, SESSTIM, Marseille, France
Edit Oláh
30Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary
Olufunmilayo I. Olopade
126Center for Clinical Cancer Genetics, The University of Chicago, Chicago, IL, USA
Ana Osorio
70Spanish Network on Rare Diseases, Madrid, Spain
127Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Madrid, Spain
Laura Papi
128Department of Experimental and Clinical Biomedical Sciences ‘Mario Serio’, Medical Genetics Unit, University of Florence, Florence, Italy
Harsh Pathak
68Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA
Celeste L. Pearce
129Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA
130Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA
Inge S. Pedersen
131Molecular Diagnostics, Aalborg University Hospital, Aalborg, Denmark
132Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark
133Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Ana Peixoto
134Department of Laboratory Genetics, Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center, Porto, Portugal
135Cancer Genetics Group, IPO Porto Research Center (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center, Porto, Portugal
Tanja Pejovic
136Department of Obstetrics & Gynecology, Providence Medical Center, Medford, OR, USA
137Providence Cancer Center, Medford, OR, USA
Pei-Chen Peng
138Department of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Beth N. Peshkin
139Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
140Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research, Georgetown University, Washington, DC, USA
Paolo Peterlongo
141Genome Diagnostics Program, IFOM - the FIRC Institute of Molecular Oncology, Milan, Italy
C. Bethan Powell
142Hereditary Cancer Program, Kaiser Permanente Northern California, San Francisco, CA, USA
Darya Prokofyeva
143Ufa University of Science and Technology, Ufa, Russia
Miquel Angel Pujana
144ProCURE, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, Barcelona, Spain
145ProCURE, IDIBGI (Girona Biomedical Research Institute), Catalan Institute of Oncology, Girona, Spain
Paolo Radice
146Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy
Muhammad U. Rashid
72Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany
147Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan
Gad Rennert
104Technion-Israel Institute of Technology, Haifa, Israel
148The Association for Promotion of Research in Precision Medicine, Haifa, Israel
George Richenberg
149MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK
Dale P. Sandler
150Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, Rockville, MD, USA
Naoko Sasamoto
119Department of Obstetrics and Gynecology, Brigham and Women’s Hospital, Boston, MA, USA
151Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, USA
Veronica W. Setiawan
152Department of Population and Public Health Sciences, University of Southern California, Los Angeles, CA, USA
Priyanka Sharma
153Department of Internal Medicine, Division of Medical Oncology, University of Kansas Medical Center, Westwood, KS, USA
Weiva Sieh
83Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
154Department of Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA
155Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Christian F. Singer
156Dept of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
Katie Snape
157Medical Genetics Unit, St George’s, University of London, London, UK
Anna P. Sokolenko
88Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, St. Petersburg, Russia
Penny Soucy
158Genomics Center, Centre Hospitalier Universitaire de Québec – Université Laval Research Center, Québec City, QC, Canada
Melissa C. Southey
116Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia
159Department of Clinical Pathology, Melbourne Medical School, University of Melbourne, Parkville, Victoria, Australia
160Cancer Epidemiology Division, Cancer Council Victoria, East Melbourne, Victoria, Australia
Dominique Stoppa-Lyonnet
161Genetics Department, Institut Curie, Paris, France
162Unité INSERM U830, Paris, France
163Université Paris Cité, Paris, France
Rebecca Sutphen
164Health Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, USA
Christian Sutter
165Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany
Manuel R. Teixeira
134Department of Laboratory Genetics, Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center, Porto, Portugal
135Cancer Genetics Group, IPO Porto Research Center (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center, Porto, Portugal
166Department of Pathology and Molecular Immunology, School of Medicine and Biomedical Sciences (ICBAS), University of Porto, Porto, Portugal
Kathryn L. Terry
120Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
167Obstetrics and Gynecology Epidemiology Center, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
Liv Cecilie V. Thomsen
21Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway
22Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway
168Medical Birth Registry of Norway, Norwegian Institute of Public Health, Norway
Marc Tischkowitz
169Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, QC, Canada
170Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK
Amanda E. Toland
2Department of Internal Medicine, Division of Human Genetics, The Ohio State University, Columbus, OH, USA
171Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA
Toon Van Gorp
172Division of Gynecologic Oncology, University Hospital Leuven, Leuven, Belgium
173Leuven Cancer Institute, University of Leuven, Leuven, Belgium
Ana Vega
107Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain
108Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain
174Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain
Digna R. Velez Edwards
175Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN, USA
Penelope M. Webb
176Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
Jeffrey N. Weitzel
177Clinical Cancer Genomics, City of Hope, Duarte, CA, USA
Nicolas Wentzensen
178Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
Alice S. Whittemore
97Department of Epidemiology & Population Sciences, Stanford University School of Medicine, Stanford University, Stanford, CA, USA
179Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA
Stacey J. Winham
180Department of Quantitative Health Sciences, Mayo Clinic College of Medicine, Rochester, MN, USA
Anna H. Wu
181Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Siddhartha Yadav
182Department of Oncology, Mayo Clinic, Rochester, MN, USA
Yao Yu
83Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Argyrios Ziogas
10Department of Epidemiology, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, CA, USA
Andrew Berchuck
183Department of Gynecologic Oncology, Duke University Hospital, Durham, NC, USA
Fergus J. Couch
184Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
Ellen L. Goode
180Department of Quantitative Health Sciences, Mayo Clinic College of Medicine, Rochester, MN, USA
Marc T. Goodman
185Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Alvaro N. Monteiro
186Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA
Kenneth Offit
187Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
188Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
189AnaNeo Therapeutics, New York, NY, USA
Susan J. Ramus
190School of Clinical Medicine, Faculty of Medicine and Health, University of NSW Sydney, Sydney, New South Wales, Australia
191Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, New South Wales, Australia
Harvey A. Risch
192Chronic Disease Epidemiology, Yale School of Medicine, New Haven, CT, USA
Joellen M. Schildkraut
193Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA
Mads Thomassen
194Department of Clinical Genetics, Odense University Hospital, Odense, Denmark
195Clinical Genome Center, Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Jacques Simard
158Genomics Center, Centre Hospitalier Universitaire de Québec – Université Laval Research Center, Québec City, QC, Canada
196Department of Molecular Medicine, Faculty of Medicine, Université Laval, Québec City, QC, Canada
Douglas F. Easton
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
100Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK
Michelle R. Jones
197Center for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Georgia Chenevix-Trench
198Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
Simon A. Gayther
197Center for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Antonis C. Antoniou
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Paul D.P. Pharoah
138Department of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Posted March 04, 2024.
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk
Daniel R. Barnes, Jonathan P. Tyrer, Joe Dennis, Goska Leslie, Manjeet K. Bolla, Michael Lush, Amber M. Aeilts, Kristiina Aittomäki, Nadine Andrieu, Irene L. Andrulis, Hoda Anton-Culver, Adalgeir Arason, Banu K. Arun, Judith Balmaña, Elisa V. Bandera, Rosa B. Barkardottir, Lieke P.V. Berger, Amy Berrington de Gonzalez, Pascaline Berthet, Katarzyna Białkowska, Line Bjørge, Amie M. Blanco, Marinus J. Blok, Kristie A. Bobolis, Natalia V. Bogdanova, James D. Brenton, Henriett Butz, Saundra S. Buys, Maria A. Caligo, Ian Campbell, Carmen Castillo, Kathleen B.M. Claes, GEMO Study Collaborators, EMBRACE Collaborators, Sarah V. Colonna, Linda S. Cook, Mary B. Daly, Agnieszka Dansonka-Mieszkowska, Miguel de la Hoya, Anna deFazio, Allison DePersia, Yuan Chun Ding, Susan M. Domchek, Thilo Dörk, Zakaria Einbeigi, Christoph Engel, D. Gareth Evans, Lenka Foretova, Renée T. Fortner, Florentia Fostira, Maria Cristina Foti, Eitan Friedman, Megan N. Frone, Patricia A. Ganz, Aleksandra Gentry-Maharaj, Gord Glendon, Andrew K. Godwin, Anna González-Neira, Mark H. Greene, Jacek Gronwald, Aliana Guerrieri-Gonzaga, Ute Hamann, Thomas v.O. Hansen, Holly R. Harris, Jan Hauke, Florian Heitz, Frans B.L. Hogervorst, Maartje J. Hooning, John L. Hopper, Chad D Huff, David G. Huntsman, Evgeny N. Imyanitov, kConFab Investigators, Louise Izatt, Anna Jakubowska, Paul A. James, Ramunas Janavicius, Esther M. John, Siddhartha Kar, Beth Y. Karlan, Catherine J. Kennedy, Lambertus A.L.M. Kiemeney, Irene Konstantopoulou, Jolanta Kupryjanczyk, Yael Laitman, Ofer Lavie, Kate Lawrenson, Jenny Lester, Fabienne Lesueur, Carlos Lopez-Pleguezuelos, Phuong L. Mai, Siranoush Manoukian, Taymaa May, Iain A. McNeish, Usha Menon, Roger L. Milne, Francesmary Modugno, Jennifer M. Mongiovi, Marco Montagna, Kirsten B. Moysich, Susan L. Neuhausen, Finn C. Nielsen, Catherine Noguès, Edit Oláh, Olufunmilayo I. Olopade, Ana Osorio, Laura Papi, Harsh Pathak, Celeste L. Pearce, Inge S. Pedersen, Ana Peixoto, Tanja Pejovic, Pei-Chen Peng, Beth N. Peshkin, Paolo Peterlongo, C. Bethan Powell, Darya Prokofyeva, Miquel Angel Pujana, Paolo Radice, Muhammad U. Rashid, Gad Rennert, George Richenberg, Dale P. Sandler, Naoko Sasamoto, Veronica W. Setiawan, Priyanka Sharma, Weiva Sieh, Christian F. Singer, Katie Snape, Anna P. Sokolenko, Penny Soucy, Melissa C. Southey, Dominique Stoppa-Lyonnet, Rebecca Sutphen, Christian Sutter, Manuel R. Teixeira, Kathryn L. Terry, Liv Cecilie V. Thomsen, Marc Tischkowitz, Amanda E. Toland, Toon Van Gorp, Ana Vega, Digna R. Velez Edwards, Penelope M. Webb, Jeffrey N. Weitzel, Nicolas Wentzensen, Alice S. Whittemore, Stacey J. Winham, Anna H. Wu, Siddhartha Yadav, Yao Yu, Argyrios Ziogas, Andrew Berchuck, Fergus J. Couch, Ellen L. Goode, Marc T. Goodman, Alvaro N. Monteiro, Kenneth Offit, Susan J. Ramus, Harvey A. Risch, Joellen M. Schildkraut, Mads Thomassen, Jacques Simard, Douglas F. Easton, Michelle R. Jones, Georgia Chenevix-Trench, Simon A. Gayther, Antonis C. Antoniou, Paul D.P. Pharoah
medRxiv 2024.02.29.24303243; doi: https://doi.org/10.1101/2024.02.29.24303243
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (420)
- Allergy and Immunology (744)
- Anesthesia (217)
- Cardiovascular Medicine (3208)
- Dermatology (270)
- Emergency Medicine (476)
- Epidemiology (13211)
- Forensic Medicine (19)
- Gastroenterology (887)
- Genetic and Genomic Medicine (5041)
- Geriatric Medicine (469)
- Health Economics (770)
- Health Informatics (3167)
- Health Policy (1121)
- Hematology (419)
- HIV/AIDS (997)
- Medical Education (467)
- Medical Ethics (125)
- Nephrology (512)
- Neurology (4783)
- Nursing (253)
- Nutrition (708)
- Oncology (2463)
- Ophthalmology (698)
- Orthopedics (277)
- Otolaryngology (336)
- Pain Medicine (318)
- Palliative Medicine (89)
- Pathology (528)
- Pediatrics (1272)
- Primary Care Research (546)
- Public and Global Health (7344)
- Radiology and Imaging (1662)
- Respiratory Medicine (962)
- Rheumatology (471)
- Sports Medicine (413)
- Surgery (532)
- Toxicology (69)
- Transplantation (227)
- Urology (199)